Bruce G. Haffty, MD, is RSNA chair for 2020. Dr. Haffty is associate vice chancellor, Cancer Programs, at Rutgers Biomedical and Health Sciences. He also serves as professor and chairman in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School.
As RSNA chair, Dr. Haffty will lead the board in its continued focus on bringing value to RSNA membership in North America and throughout the world through its offerings in research and education.
Dr. Haffty has volunteered with RSNA in a number of roles, including as third vice president and as co-chair of the Bolstering Oncoradiologic and Oncoradiotherapeutic Skills for Tomorrow (BOOST) Program. At RSNA 2009, he delivered the Annual Oration in Radiation Oncology. Dr. Haffty was named RSNA Outstanding Educator in 2013. Dr. Haffty has been on the RSNA Board of Directors since 2014, most recently serving as liaison for science. He also served on the RSNA News editorial board.
Dr. Haffty completed his medical school and residency training at Yale University School of Medicine and spent the next 18 years specializing in breast, head and neck cancers in Yale's Department of Therapeutic Radiology. He served on the faculty at Yale from 1988 through 2005. Dr. Haffty was promoted to professor of therapeutic radiology in 2000 and served as residency program director and vice chairman and clinical director.
Dr. Haffty has authored or co-authored 50 books, book chapters and theses, more than 400 peer-reviewed articles and numerous editorials and letters. Dr. Haffty is a leader in national clinical trials and is currently co-investigator on several national clinical trials through the NRG Oncology and Alliance for Clinical Trials in Oncology cooperative groups.
At Rutgers Robert Wood Johnson Medical School, New Jersey Medical School and Cancer Institute of New Jersey — now part of Rutgers, Dr. Haffty spearheaded the expansion of the Radiation Oncology Program and developed residency programs in radiation oncology and medical physics — the only such programs in the state of New Jersey.
Through his extensive work with the American Society for Radiation Oncology, Dr. Haffty served as the founding president of the Association of Directors of Radiation Oncology Programs (ADROP) in 2000, providing tools and resources to advance the quality of residency training and education in radiation oncology.
Dr. Haffty's research on new methods of delivering radiation therapy for breast cancer has created unique factors associated with outcomes, paving the way for molecular targeted therapies in combination with radiation.
In addition to editing the comprehensive Handbook of Radiation Oncology, Dr. Haffty has served on numerous editorial boards. He currently serves on the editorial board of The Breast Journal and serves as deputy editor of Journal of Clinical Oncology.
Dr. Haffty is a past president of the American Radium Society, past chairman of the Residency Review Committee in Radiation Oncology, past president of the American Board of Radiology and past president of American Society for Radiation Oncology.